Loading...

Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

India’s first dedicated Medical Device Park

Image

09-Nov-15 Chief Minister of Andhra Pradesh, Chandrababu Naidu has taken in-principle decision to develop a dedicated 200 acre industrial park for the manufacture of medical devices in his state. The 200 acre exclusive park will spur domestic production of medical devices, and help reduce import dependency in this sector while creating employment and economic growth. [image: ET Healthworld]

Read More

Hanmi Pharmaceutical signs Sanofi diabetes mega deal

Image

06-Nov-15 Korea's Hanmi Pharmaceutical has signed a contract with Sanofi to export USD4 bn worth of diabetes treatment technology, in a deal worth almost 30% of the value of the entire Korean pharma industry. Sanofi gains an exclusive worldwide license to develop and commercialize drugs based on the materials, except in Korea and China, where Hanmi retains co-commercialization rights. [image: Business Korea]

Read More

Fair Trade Commission investigating Siemens Korea

Image

05-Nov-15 Korea's Fair Trade Commission has launched an investigation of Siemens Korea’s alleged unfair business practices in the field of medical equipment. According to the FTC, Siemens has refused to provide MRI and CT equipment software ownership and provided only the right to use the software.

Read More

Investment lifts quality at Vietnam's public hospitals

Image

05-Nov-15 By utilising their budgets and borrowing funds, many hospitals in Vietnam have improved quality and raised confidence. In Hanoi 13 out of 41 public hospital and six health centres are taking part in privatisation programmes and there are 48 co-operation schemes allowing investors to invest in medical equipment. [image: VNA]

Read More

China launches pilot scheme to ease drug approvals

Image

05-Nov-15 China has launched a three-year pilot scheme to loosen approvals for new drugs, the country's food and drug regulator said, as Beijing looks to help stimulate innovation in the country's pharmaceutical sector. The trial will allow research and development bodies to seek drug approvals, which are currently restricted to drug manufacturers. [image: ET Healthworld]

Read More